|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/426 | |
| A61K 31/427 | |||
| A61K 31/4439 | |||
| A61K 31/506 | |||
| A61K 31/519 | |||
| A61K 31/5377 | |||
| A61K 31/635 | |||
| A61K 45/06 | |||
| A61P 17/02 | |||
| A61K 31/197 | |||
| A61K 31/53 |
| (11) | Number of the document | 3291811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16719430.7 |
| Date of filing the European patent application | 2016-05-02 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/059734 |
| Date | 2016-05-02 |
| (87) | Number | WO 2016/177660 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 15166516 | 2015-05-06 | EP |
| (72) |
HIRTH-DIETRICH, Claudia, DE
SANDNER, Peter, DE
STASCH, Johannes-Peter, IT
HAHN, Michael, DE
FOLLMANN, Markus, DE
VAKALOPOULOS, Alexandros, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC) |
| THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC) |